Background Bare metal stents may cause complications like fibrous encapsulation, granulation and tracheal stenosis. We investigated the behaviour of three commercially available stents in vivo (rabbits) and in vitro (coculture of those stents with epithelial and fibroblast cell lines). Also, we investigated whether development of tracheal stenosis could be predicted by any biological marker.
Introduction
Tracheal stents are widely used to treat malignant and benign tracheal stenoses not suitable for surgery [1, 2] . Silicone stents are frequently used in benign conditions, but require rigid bronchoscopy and general anaesthesia [3, 4] . Moreover, mucus retention and infections are serious complications with this stent. On the other hand, an increasing array of expandable metallic stents is available, which can be inserted into the airway using a flexible bronchoscope or under fluoroscopy and then expanded to the required diameter. However, most metallic stents are associated with migration, restenosis, granulation tissue, re-epithelization and deep fibrous encapsulation, which make stent removal risky or impossible [5] [6] [7] [8] [9] [10] .
Drug-eluting stents (DESs) are platforms which deliver antiproliferative, antithrombogenic, anti-inflammatory or immunosuppressive drugs. Amongst antiproliferative drugs, sirolimus [11] , everolimus [11] [12] [13] and paclitaxel [14, 15] have all been widely used. DESs inhibit cell proliferation [16] [17] [18] , and there are theoretical reasons as to why they can be advantageous in the trachea. In this context, research aimed at the prevention of obstruction or fibrotic encapsulation is crucial. 
ORIGINAL ARTICLE
Together with the biological effects associated with the stent composition itself, radial and shear stress forces would have a marked influence on the reaction patterns of the tracheobronchial wall to metallic stents [19] . We designed an in vivo and in vitro study, aiming to investigate whether metallic stents (including paclitaxel-eluting stents) induce different tissue reactions. Rabbits were implanted with different stents, which were also cocultured with human respiratory epithelial and fibroblast cell lines. Also, we investigated whether development of tracheal stenosis could be predicted early by any of the markers included in the study.
Methods

In vivo study
Thirty adult female New Zealand rabbits were randomly assigned (10 animals per stent) to receive a paclitaxel-eluting (dose delivery 3 lg/mm 2 ) nitinol stent (Zilver PTX; Cook Medical, Bjaeverskov, Denmark), a bare nitinol stent (Zilver Flex; Cook Medical) or a cobalt-based super alloy stent (Wallstent, Boston Scientific, Natick, MA, USA). The stents were deployed percutaneously under general anaesthesia and fluoroscopic guidance. Computed tomography (CT) tracheal studies were performed under sedation 30 and 90 days after stent deployment as previously published by our Group [20] . Parameters assessed in the CT study were maximum tracheal lumen stenosis in an axial view (%), stenosis length in a sagittal view (mm) and detection of image compatible with granulomas (present or absent).
All animals were observed for any sign of respiratory distress or deterioration in general health during the 90-day duration of this experiment. Serial peripheral venous blood samples were taken throughout the study, and animals were euthanized on day 90 by intravenous pentobarbital injection, followed by tracheoscopy, tracheal lavage and necropsy performed. The following endoscopic aspects were evaluated by two independent reviewers: tracheal stenosis, granulation tissue (polyploid-like lesions), reepithelization covering the stent, fibrous reactions (fibrous bands), inflammation and secretions in the tracheal lumen (Fig. 1) .
The expression of pro-inflammatory (IL-8) and pro-fibrotic cytokines (bFGF, TGFb and VEGF) was analysed from peripheral venous blood and tracheal lavage samples using reverse transcription quantikine PCR (RT-qPCR). RNA was isolated using the High Pure RNA isolation (Roche, Mannheim, Germany), and cDNA was synthesized using an iScript cDNA synthesis kit (BioRad, Hercules, CA, USA). RT-qPCR was performed using the Stratagene Mx3500 equipment (Stratagene California, San Diego, CA, USA). b-actin expression was used as an internal control with which to normalize target gene expression.
Animal care protocols were in compliance with European Communities Council Directive (86/609/EEC), with prior approval from our local Ethics Committee.
In vitro study 
Statistical analysis
Kaplan-Meier with log-rank (Mantel-Cox) analysis was performed for comparisons of survival. Following normality testing, the student's t-test for independent samples or analysis of variance (ANOVA, with Bonferroni post hoc test) was used to compare cytokine levels between groups. For nonparametric data, the Mann-Whitney U-test or Kruskal-Wallis test was applied. For correlations, the Pearson r or Spearman rho coefficients were used, depending on sample characteristics. ROC analysis was used to investigate performance of different parameters in predicting the presence of tracheal inflammation or stenosis, and comparisons were made by chi-square test. Two-tailed P values < 0Á05 were considered to be significant. Data processing and statistical analyses were performed using IBM SPSS Statistics 20 for Windows (Armonk, New York, USA).
Results
In vivo analyses
There were no immediate deaths or major complications associated with the procedure; a 100% technical success rate was achieved for stent implantation.
Tracheoscopy data. All tracheoscopy findings are presented in Table 1 .
Survival was significantly shorter than controls for rabbits implanted with the Wallstent stent (Fig. 2a) . Short survival was associated to stent-related stenosis (Fig. 2b) , and those animals had to be euthanized before the experimental deadline.
Stenosis. The highest incidence of stenosis was observed with Wallstent group, and less stenosis was recorded for Zilver Flex (Table 1) ; nevertheless, the DES Zilver PTX was associated with the most severe stenosis in many cases. Stenosis correlated directly with the presence of inflammation (r = 0Á756, P < 0Á001), and fibrous reaction (r = 0Á521, P = 0Á002), and was inversely correlated with survival following stent implantation (r = À0Á404, P = 0Á02). Most important, stenosis was closely associated to increase in IL-8 expression in blood just 1 day after tracheal stent implantation: a 1Á19-fold increase vs. baseline had 83% sensitivity, 83% specificity, 77% positive predictive value, 88% negative predictive value and 83% accuracy to predict development of tracheal stenosis.
Granulation tissue. Granulation tissue was observed for all three stent groups, with no significant differences between them.
The Zilver PTX was the only stent for which a statistically significant number of granulomas arose in the area underlying the stent, compared with more proximal or distal stent locations, which were more commonly seen for the Wallstent group.
Re-epithelization covering the stent. Re-epithelization occurred for all animals implanted with the nitinol stents, irrespective of drug delivery; only partial re-epithelization occurred for the Wallstent group. Of the nitinol stents used, re-epithelization was most prominent for the Zilver PTX group.
Fibrous encapsulation. Fibrosis was particularly prominent in rabbits with the Zilver PTX stent, compared with other stents (P < 0Á01). This adverse effect correlated closely with the extent of re-epithelization (r = 0Á687, P < 0Á001), tracheal stenosis (r = 0Á521, P = 0Á002) and inflammation (r = 0Á48, P = 0Á004). Inflammation. Inflammation was evident for all three stent test groups and was most severe for the Wallstent (85Á7%) vs. other groups (62Á5% for Zilver PTX; 22Á2% for Zilver Flex).
Cytokine expression in tracheal lavage and peripheral blood samples Pro-inflammatory markers. Rabbits with stents expressed a higher tracheal lavage IL-8 mRNA than controls (Fig. 3a) . Il-8 mRNA levels in blood are depicted in Fig. 3b . When compared with baseline values, the mean IL-8 mRNA-folds at day 1 were 4Á49 for Wallstent, 2Á82 for Zilver Flex, 2Á53 for Zilver PTZ and 0Á9 for controls (P = 0Á029). The single highest tracheal lavage IL-8 mRNA expression (236-fold vs. control) was recorded in a rabbit fitted with a Wallstent that survived only 16 days; this animal had the most severe tracheal inflammation, granulation and secretion retention.
Pro-fibrotic gene expression. Tracheal lavage bFGF mRNA levels were lower for all stent groups vs. controls (P < 0Á01; Fig. 3c ), but they were higher than controls in blood. However, they decreased throughout the study ( Fig. 3d ; see Discussion). Tracheal lavage TGFb and VEGF mRNA levels revealed no significant differences between groups (data not shown).
In vitro analyses
Greater proliferation was noted for the Nuli-1 control cultures vs. cocultures with stents (Fig. 4a) . Conversely, MRC-5 fibroblasts showed a potent proliferative response around the Wallstent and Zilver Flex stents (Fig. 4b) . For either cell type, no viable cells could be observed by day 15 coculture with paclitaxel-delivering stents. When IL-8 levels were normalized to total cell number (IL-8/total cell number ratio), Nuli-1 cells cultured with the Wallstent had the highest IL-8 levels in the first few days of culture (Fig. 4c) . The normalized data showed more bFGF expression in Nuli-1 stent cocultures vs. controls (Fig. 4e) .
Discussion
Stenosis is the hardest problem associated with tracheal stent implantation, and rabbits with the cobalt-based stent had the highest overall incidence in our study. This adverse event was unexpectedly more severe in animals implanted with the paclitaxel-eluting stent. According to serial CT examinations that were published previously by our Group [19] , stenosis progressed from day 30 to 90 in nitinol stents (with and without paclitaxel delivery), but not in the cobalt-based alloy stent, which provoked earlier stenosis, subsequently with more early deaths in rabbits.
Tracheal stenosis was closely associated to increase in IL-8 expression in blood just 1 day after tracheal stent implantation, with good sensitivity, specificity and accuracy to predict development of stent-induced stenosis in our rabbit study. The question on the mechanisms involved in this systemic IL-8 increase remains open, but it is likely that the presence of strong local inflammation in the trachea induces a systemic inflammation also. Other unknown mechanisms, like release of the metallic components, unknown so far, might also be invoked. If extrapolated into humans, our findings would imply that development of stent-induced tracheal stenosis can be predicted when a strong early systemic inflammation is Tracheal stenosis: rated from 0 (absent) to 2 (severe); granulation tissue (polyploid-like lesions): from 0 (absent) to 1 (present); re-epithelization over the stent surface: rated from 0 (absent) to 3 (complete with stent covered by thick tissue); fibrous reaction (fibrous bands): from 0 (absent) to 2 (severe); inflammatory aspect of the tracheal surface: from 0 (absent) to 2 (severe); secretions in the tracheal lumen: from 0 (absent) to 2 (severe). Scores are presented as mean AE SEM, unless otherwise stated. *Statistical differences (P < 0Á05). **Statistical differences (P < 0Á01).
observed after stent placement, and adequate treatment could then be applied to prevent this complication. On histopathologic examination, the paclitaxel-eluting stent did not behave as expected, and it caused destruction of the epithelium and tracheal structure in seven of the animals (70%), with adherence to surrounding tissue. The higher degree of tracheal stenosis observed in the Zilver PTX vs. Zilver Flex group (which has the same pattern design and nickel-titanium alloy composition, but without drug delivery) suggests a causal role for paclitaxel. Our findings suggest that paclitaxel at high concentrations is highly injurious to tracheal tissue. While these concentrations might be adequate to prevent neo-intimal hyperplasia following intravascular insertion [21, 22] , where blood flow clears a portion of the drug delivered, effective clearing is unlikely to occur in the trachea, as the natural mucociliary clearing mechanism can be impaired by stent insertion. Moreover, the lipophilic nature of paclitaxel might enhance cellular uptake, thereby increasing cytotoxicity with subsequent destruction of the normal epithelium, as we described previously [20] .
Re-epithelization implies a complete covering of the stent that, together with deep fibrous encapsulation, makes stent removal risky or even impossible. The intensity of fibrosis correlated with re-epithelization, and both were more prominent for the paclitaxel-delivering stent. Fibrosis correlated also with the degree of inflammation and stenosis, which suggests that a complex process involving tissue injury and inadequate repair takes place in rabbits following stent insertion [23] , especially with paclitaxel-delivering stents.
Inflammation was more prominent in the Wallstent group, followed by Zilver PTX, and correlated directly with stenosis, granulation tissue and fibrosis. Moreover, the Wallstent group showed the highest IL-8 production in our in vivo and in vitro study.
As opposed to IL-8, all stent groups had bFGF mRNA downregulated in tracheal lavage samples compared to controls (Fig. 3c) . However tracheal lavage bFGF correlated positively with survival in our study, which emphasizes the protective role played by this cytokine during tissue injury and repair [24] . It is important to note that according to some studies, bFGF expression is particularly high in the early phases of granulation tissue formation and then gradually decreases in the mature phase of postintubation tracheal stenosis [25] , which is compatible with our findings in blood samples in our study (Fig. 3d) .
As with other lesions, granulation tissue formation was higher for the Wallstent group, especially in areas proximal or distal to the stents. As all stents had the same size (8 9 40 mm), the differences found in biological reactions to the stents were probably related to their different geometric structures and/or composition. The Wallstent was made of stainless steel filaments in the past and, more recently, an alloy containing cobalt, chromium, nickel, molybdenum and manganese, amongst other elements. The filaments are organized in a criss-cross pattern and have an open strut structure at both the proximal and distal ends, which may be responsible for the tensionassociated lesions observed at those locations. On the other hand, Zilver Flex and PTX are made of a nickel-titanium (nitinol) super alloy with memory shape and a zigzag structure, with less tension exerted on the tracheal wall. By building a rabbit trachea numerical model, our Group was able to analyse the behaviour of the trachea before and after deployment of Zilver Flex and Wallstent stents (the same that were used for this present study) and thus showed that tensile stent-associated forces may lead to a greater tracheal epithelium response within the stented region [26] . 
Role of the in vitro study
Our in vivo rabbit study involved both biological effects derived from the composition of the stent itself and mechanical forces exerted by the stent on the surrounding tissue, and distinguishing between the two types of influence is not a trivial exercise. Aiming to overcome this problem, we combined in vivo experiments with co-incubation of the same metallic stents with epithelial and fibroblast cell lines in vitro.
All stents induced significantly higher IL-8 levels in culture compared to controls, with the Wallstent group generating the most IL-8, which agreed with our in vivo data suggesting that composition of the stent itself was the cause of the systemic pro-inflammatory response observed in rabbits. We speculate that this systemic inflammation might be related to the release of metallic elements from the stent alloys and also suspect that the results obtained in our in vitro study could be caused, at least in part, by that release (lixiviation) [27] . These aspects deserve further investigation in the future.
Limitations of the study
The high rate of complications found with the paclitaxel-eluting stent was probably related to the high and fast delivery of this drug to the surrounding tracheal tissue. Establishing the correct dosage for specific tissue targets is therefore important [28] . A previous in vitro study from our group suggested that cell viability could be better preserved using a paclitaxel-delivering stent with a dose delivery of 1 lg/mm 2 , rather than the 3 lg/mm 2 currently delivered by the Zilver PTX stent [29] , then supporting the concept that too high doses of paclitaxel have played a critical role in the destructive patterns that we observed with this stent implanted on rabbits. Using stents in conjunction with other antiproliferative drugs [30] might represent plausible alternatives, and drug-eluting bio absorbable stents might also play a role in the future [31] . Although performance of the in vivo experiments with stents inserted in a normal (nonstenotic) rabbit trachea is another limitation in our study, our approach provided a uniform baseline status for all animals, then allowing investigation of damage caused by the stents themselves. Our study was performed in small animals that required narrow vascular stent insertion, and it could be argued that our results do not readily extrapolate to humans. We would agree with this, but we also believe that the combination of our in vitro and in vivo approaches provides relevant insights into the pathophysiological mechanisms that are involved in stentassociated tissue damage.
Conclusions
Metallic stents, with and without paclitaxel delivery, induced a marked pro-inflammatory response in the rabbit trachea. The paclitaxel-eluting nitinol stent provoked a stronger reaction than bare nitinol, and the cobalt-based stent had the highest pro-inflammatory response. Most important, tracheal stenosis was closely associated to increase in IL-8 expression in blood just 1 day after tracheal stent implantation. If extrapolated into humans, our findings would imply that development of stentinduced tracheal stenosis can be predicted in advance when a strong systemic inflammation is observed early after stent placement, and adequate treatment could then be applied to prevent this complication. 
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